Results for tag: "Apixaban"

Apixaban is a direct factor Xa inhibitor, a type of anticoagulant drug used to treat and prevent blood clots. It is used to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and to treat and prevent deep vein thrombosis and pulmonary embolism. Apixaban is also used to reduce the risk of recurrent deep vein thrombosis and pulmonary embolism following initial treatment. It is a member of the class of drugs known as hematological drugs, which are used to treat and prevent blood-related disorders. Apixaban is available in both oral and injectable forms, and is typically prescribed for long-term use. It is generally well-tolerated, with the most common side effects being bleeding and bruising. Apixaban is a relatively new drug, having been approved by the US Food and Drug Administration in 2012. Companies in the Apixaban market include Bristol-Myers Squibb, Pfizer, Daiichi Sankyo, and Bayer. Show Less Read more